Lei Wang, Lei Wang, Lei Wang, Wuxiyar Otkur, Aman Wang, Wen Wang, . . . Ji-Wei Liu. (2022). Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway. Frontiers Media S.A..
Chicago Style (17th ed.) CitationLei Wang, et al. Norcantharidin Overcomes Vemurafenib Resistance in Melanoma by Inhibiting Pentose Phosphate Pathway and Lipogenesis via Downregulating the MTOR Pathway. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationLei Wang, et al. Norcantharidin Overcomes Vemurafenib Resistance in Melanoma by Inhibiting Pentose Phosphate Pathway and Lipogenesis via Downregulating the MTOR Pathway. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.